Joost Beusekamp

Alumnus

My name is Joost Beusekamp and I am 27 years of age. In 2018, I started with my MD/PhD program focusing on serum electrolytes in patients with heart failure. Currently, I am in the last year of this program, which combines clinical internships with your research projects. In Augustus 2020, I received my medical degree and since this is the last year of my research period, I hope to obtain my PhD in the upcoming year.
Supervisors: prof. Peter van der Meer MD PhD, prof. Adriaan Voors MD PhD, and Jasper Tromp MD PhD.

Contact details

Current activities

–        Urinary potassium
–        Natriuresis
–        Post-hoc analyses of the EMPA-RESPONSE-AHF trial (empagliflozin in acute HF)
–        Precipitating factors in acute HF (REPORT-HF, in collaboration with DUKE-NUS, Singapore)

My publications

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).

Damman K, Beusekamp JC, Boorsma EM, Swart HP, Smilde TDJ, Elvan A, van Eck JWM, Heerspink HJL, Voors AA. Eur J Heart Fail. 2020

view on publisher site

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.

Beusekamp JC, Tromp J, Cleland JGF, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Ouwerkerk W, van Veldhuisen DJ, Voors AA, van der Meer P. JACC Heart Fail. 2019

view on publisher site